医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Indonesia’s Bali Royal Hospital Selects UpToDate as its Evidence-Based Clinical Decision Support System of Choice

2013年02月15日 AM12:25
このエントリーをはてなブックマークに追加


 

WALTHAM, Mass.

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Bali Royal Hospital has selected UpToDate® as its evidence-based clinical decision support system. The hospital represents the first UpToDate client in Indonesia.

Bali Royal Hospital opened its doors in 2010 to provide comprehensive medical services to local patients and tourists in the city of Bali and across East Indonesia. The facility selected UpToDate to increase physician adoption of the latest industry best practices across its four centers of excellence—in vitro fertilization, endoscopy, neuroscience and cosmetic surgery— as well as homecare and general medical practice.

“We recognize the challenges of keeping up with the rapid pace of medical discovery and technological advancement and want to ensure that our clinicians have access to the latest industry evidence at the point of care,” said Ida Ayu Oka Purnama Wati, Vice Director, Bali Royal Hospital. “Since deploying UpToDate, our clinicians have developed a deeper knowledge of clinical best practices and have greater confidence that they are providing patients with the best care possible.”

UpToDate’s clinical guidance is already influencing care decisions at Bali Royal. One recent example is that of a European tourist diagnosed with Cerebral Salt Wasting Syndrome (CSWS), a rare endocrine condition characterized by low blood sodium and severe dehydration. Treatment of CSWS is complex and clinical management is intensive.

“Following the clinical recommendation from UpToDate, the patient was successfully treated with fludrocortisone and has since returned home,” said Agus Suardika, M.D., Head of International Service, Bali Royal Hospital. “The confidence our clinicians have in UpToDate is such that they were comfortable adopting a new treatment plan for CSWS that ultimately resulted in a successful outcome.”

“We are pleased to work with Bali Royal Hospital as our newest client in Southeast Asia,” said Denise Basow, M.D., Vice President/General Manager and Editor-in-Chief, UpToDate at Wolters Kluwer Health, Clinical Solutions. “Research studies continue to confirm the effectiveness of UpToDate as a resource for elevating care delivery, and clinicians worldwide trust our content to deliver the best advice at the point of care.”

About UpToDate

UpToDate® is an evidence-based, physician-authored clinical knowledge system which clinicians trust to make the right point-of-care decisions. UpToDate’s more than 5,100 world-renowned physician authors, editors and peer reviewers use a rigorous editorial process to synthesize the most recent medical information into trusted, evidence-based recommendations that are proven to improve patient care and quality. More than 700,000 clinicians in 158 countries and almost 90% of academic medical centers in the U.S. rely on UpToDate, and more than 30 research studies confirm UpToDate’s widespread usage and association with improved patient care and hospital performance, including reduced length of stay, adverse complications and mortality.

UpToDate is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).

CONTACT

Wolters Kluwer Health | UpToDate
André Rebelo, +1-781-392-2411
Public
& Analyst Relations Manager
arebelo@uptodate.com

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024